Peer Review And Anonymity

The Scientist, July 11, 1994, page 13), "revealing a reviewer's identity is a good way to dilute or eliminate valuable and often valid criticism." Yet if you, as a reviewer, are confident in your opinion, then why should you hide your name? Could it be that anonymous peer review (APR) is grounded in fear of looking foolish in case you (the reviewer) turn to be wrong? But to face the risk of being wrong is an inherent part of the vo

Written byAlexander Berezin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Yet if you, as a reviewer, are confident in your opinion, then why should you hide your name?

Could it be that anonymous peer review (APR) is grounded in fear of looking foolish in case you (the reviewer) turn to be wrong? But to face the risk of being wrong is an inherent part of the vow we all implicitly take in choosing an academic career in the first place.

I see no ethical base for peer-review anonymity. Most newspapers (including The Scientist) will not publish anonymous letters. In most other creative areas (music, poetry, visual and performing arts, architecture, and so forth), criticism--even the most harsh--is invariably open. Only science, by some strange twist (perhaps a hidden inferiority complex) has developed APR. To my knowledge, the legality of APR was never clearly established. If contested, it will likely run into conflict-of-interest trouble. (Peer reviewers and the authors are competitors ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies